Cohort studyindependent cross-checkabstract checked I-CHM-115 standard review

Lifetime health problems after childhood cancer

The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).

Overview

Bhakta N et al.. Lancet 2017 · PMID 28890157 · DOI 10.1016/S0140-6736(17)31610-0

By age 50, survivors had on average 4.7 serious health conditions vs 2.3 in people without childhood cancer.

Does the study support the specific claim? Yes · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Count all health problems in survivors

How was the study done?

Clinical assessment cohort

How many people, animals or samples were studied?

3010 assessed survivors

What was actually found?

High burden

How large was the observed effect?

4.7 vs 2.3 serious conditions by age 50

What do the results mean in everyday life?

Survivors need lifelong check-ups

What are the study's limitations?

Single centre; old treatments

What does it say about Elawady's specific claim?

Supports the burden claim

Do the results apply to Germany and Europe?

Moderate

What can explicitly not be concluded from this study?

Cannot weigh this against the lives saved

Scientific in-depth review

1. Full reference

Authors
Bhakta N et al.
Journal
Lancet
Year
2017
Identifier
PMID 28890157 DOI 10.1016/S0140-6736(17)31610-0
Verification
verified – PubMed efetch 2026-10-26 (PublicationType and CommentsCorrections checked); Crossref 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

NCI, St Baldrick's Foundation, ALSAC.

2. Research question

What is the cumulative burden of chronic health conditions in adult survivors of childhood cancer?

3. Study design and population

Study design
Cohort study – Retrospective cohort with prospective clinical assessment (SJLIFE)
Population

10-year survivors treated at St Jude, aged >=18, and community controls

Country

USA

Period

Not stated in abstract; eligibility assessed as of 30 June 2015

Sample size

5522 eligible; 3010 clinically assessed

Inclusion and exclusion criteria

Survived >=10 years, age >=18

4. Methods and endpoints

Exposure / intervention

Childhood cancer treatment (21 exposure variables)

Comparator

Age- and sex-matched community controls

Endpoints

168 chronic conditions graded by CTCAE

Statistical methods

Mean cumulative count; marked-point-process regression; multiple imputation

5. Actual results

Results

Cumulative incidence at age 50: 99.9% for any grade 1-5 condition and 96.0% for grade 3-5. Mean cumulative count by age 50: 17.1 conditions (4.7 grade 3-5) vs 9.2 (2.3 grade 3-5) in controls. Higher burden with older age at diagnosis, treatment era and higher brain/chest radiation doses.

Absolute risks

Grade 3-5 conditions by age 50: 4.7 per survivor vs 2.3 per control

Authors' conclusion

The burden of chronic conditions in survivors is substantial and highly variable.

6. Strengths

  • Clinical assessment rather than self-report
  • Comprehensive grading

7. Weaknesses

  • Single institution
  • 45.5% not clinically evaluable (imputed)
  • Grade 3 includes conditions such as treated hypertension

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Imputation for missing participants; single centre.

9. Assessment of the statistical interpretation

Burden ratio about 2.0 for grade 3-5 conditions vs controls (stats/C-CHM-06.py).

10. Relevance to the specific claim

Supports the claim that survivors carry a large burden of chronic disease; indicates the archive's figure is not an exaggeration of the total burden but misattributes '62%' to severe conditions.

11. Independent contrary findings

Gibson 2018 (I-CHM-114): declining burden in later eras.

12. Transferability to Germany and Europe

Applicable with caution.

13. Overall methodological judgement

Strong evidence of high cumulative burden.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biassome concerns
Precision of resultshigh
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Burden under modern protocols.

15. Linked fact checks